title: Response to Comment on Beltrand et al. Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations. Diabetes Care 2015;38:2033-2041.
authors.affiliation: Service Endocrinologie, Gynécologie et Diabétologie Pédiatrique, Hôpital Universitaire Necker Enfants Malades Paris, Assistance Publique-Hôpitaux de Paris, Paris, France; Faculté de Médecine, Paris Descartes-Université Sorbonne Paris Cité, Paris, France; INSERM U1016, Institut Cochin, Paris, France; and Institut Imagine, Paris Descartes-Université Sorbonne Paris Cité, Paris, France.
authors.forename: Jacques
authors.initials: J
authors.lastname: Beltrand
authors.affiliation: Service Endocrinologie, Gynécologie et Diabétologie Pédiatrique, Hôpital Universitaire Necker Enfants Malades Paris, Assistance Publique-Hôpitaux de Paris, Paris, France; Faculté de Médecine, Paris Descartes-Université Sorbonne Paris Cité, Paris, France; INSERM U1016, Institut Cochin, Paris, France; and Institut Imagine, Paris Descartes-Université Sorbonne Paris Cité, Paris, France michel.polak@nck.aphp.fr.
authors.forename: Michel
authors.initials: M
authors.lastname: Polak
mesh_terms: D003920:Diabetes Mellitus; D006801:Humans; D009154:Mutation; D015221:Potassium Channels / Q000235:genetics*; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics; D013453:Sulfonylurea Compounds
chemical_list: D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds